Jagsonpal Pharmaceuticals Limited has informed the Exchange about press release dated 21-Feb-2022 titled Intimation for Public Announcement Under Regulations 3(1) and 4 read with Regulations 13(1), 14 And 15(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011